Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
The incidence of postengraftment invasive aspergillosis (IA) in hematopoietic stem cell transplant (HSCT) recipients increased during the 1990s. We determined risks for IA and outcomes among 1682… Expand
Cytomegalovirus in hematopoietic stem cell transplant recipients.
- P. Ljungman, M. Hakki, M. Boeckh
- Medicine
- Infectious disease clinics of North America
- 1 June 2010
This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV… Expand
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.
- W. G. Nichols, K. Guthrie, L. Corey, M. Boeckh
- Medicine
- Clinical infectious diseases : an official…
- 1 November 2004
BACKGROUND
Community-acquired respiratory viruses, such as influenza virus, are thought to be major causes of morbidity and mortality in patients who had undergone hematopoietic stem cell… Expand
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
- W. G. Nichols, L. Corey, T. Gooley, C. Davis, M. Boeckh
- Medicine
- Blood
- 1 August 2001
Parainfluenza virus (PIV) infections may be significant causes of morbidity and mortality in patients undergoing stem cell transplantation, but data regarding their impact on transplant-related… Expand
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
- D. Zerr, L. Corey, H. W. Kim, M. Huang, Long Nguy, M. Boeckh
- Medicine
- Clinical infectious diseases : an official…
- 1 April 2005
BACKGROUND
Although human herpesvirus 6 (HHV-6) is known to reactivate during hematopoietic stem cell transplantation (HSCT), the clinical significance of this finding is controversial.
METHODS
We… Expand
Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and…
- H. Hirsch, R. Martino, K. Ward, M. Boeckh, H. Einsele, P. Ljungman
- Medicine
- Clinical infectious diseases : an official…
- 28 September 2012
Respiratory viruses have been recognized as a significant cause of morbidity and mortality in patients with leukemia and those undergoing hematopoietic stem cell transplantation. The risk for lower… Expand
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
- M. Boeckh, W. G. Nichols, G. Papanicolaou, R. Rubin, J. Wingard, J. Zaia
- Medicine
- Biology of blood and marrow transplantation…
- 1 September 2003
Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after hematopoietic stem cell transplantation. Significant progress has been made in the prevention of CMV disease over the… Expand
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.
- M. Green, W. Leisenring, +5 authors M. Boeckh
- Medicine
- Blood
- 15 August 2013
The association between cytomegalovirus (CMV) reactivation and relapse was evaluated in a large cohort of patients with acute myeloid leukemia (AML) (n = 761), acute lymphoblastic leukemia (ALL) (n =… Expand
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Prophylactic fluconazole prevents candidiasis; however, this drug has no activity against molds. We performed a randomized trial to determine whether prophylactic itraconazole prevents invasive mold… Expand
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
The incidence of invasive mold infections has increased during the 1990s among patients undergoing allogeneic hematopoietic stem cell transplantation (HCT) after myeloablative conditioning. In this… Expand